Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Increase in Short Interest

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 394,700 shares, an increase of 94.1% from the November 30th total of 203,400 shares. Based on an average daily volume of 2,390,000 shares, the days-to-cover ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AEMD. StockNews.com began coverage on Aethlon Medical in a research report on Thursday. They set a “sell” rating on the stock. HC Wainwright reiterated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Price Performance

Shares of AEMD traded up $0.02 during midday trading on Friday, hitting $0.61. 3,053,982 shares of the company traded hands, compared to its average volume of 2,232,336. The stock has a 50-day moving average of $0.41 and a 200-day moving average of $0.43. The firm has a market cap of $8.46 million, a P/E ratio of -0.21 and a beta of 1.79. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.